Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation

Emma Tudini; Michael C. Quinn; Sebastian Lunke; Anthony Marty; Gladys Ho; Andrew Dubowsky; Johanna Hadler; Melissa Ellul; Rahul Krishnaraj; John V. Pearson; Cristina Fortuño; Kenneth Doig; Renée Gallagher; Belinda Chong; John Beilby; Sarah L. King‐Smith; Chiyan Lau; John Christodoulou; Bruce Bennetts; Emma Hackett; Michael W. Black; Victoria Beshay; Marcel E. Dinger; Mark R. Davis; Ben Lundie; Karin S. Kassahn; Huong Quang Le; Michael Christie; Kathy Cox; Tiffany Boughtwood; Lucas Dejong; Amanda J. Hooper; Leanne Baxter; Katrina Fisk; Kristian Brion; Michael Hipwell; Pak Leng Cheong; Georgina E. Hollway; Kátia Nones; Evelyn Douglas; Song Gao; James Andrews; Kathryn Friend; Huei San Leong; Mary McPhillips; Naomi L. Baker; David Lawrence; Kristen Palmer; Andrew Fellowes

doi:10.1016/j.ajhg.2022.10.006

Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation

Emma Tudini(QIMR Berghofer Medical Research Institute), Michael C. Quinn(New South Wales Department of Health), Sebastian Lunke(Royal Children's Hospital), Anthony Marty(Melbourne Genomics Health Alliance), Gladys Ho(The University of Sydney), Andrew Dubowsky(South Australia Pathology), Johanna Hadler(South Australia Pathology), Melissa Ellul(South Australia Pathology), Rahul Krishnaraj(Children's Hospital at Westmead), John V. Pearson(The University of Queensland), Cristina Fortuño(QIMR Berghofer Medical Research Institute), Kenneth Doig(The University of Melbourne), Renée Gallagher(Queensland Health), Belinda Chong(New South Wales Department of Health), John Beilby(Queen Elizabeth II Medical Centre), Sarah L. King‐Smith(South Australia Pathology), Chiyan Lau(Queensland Health), John Christodoulou(The University of Melbourne), Bruce Bennetts(The University of Sydney), Emma Hackett(Children's Hospital at Westmead), Michael W. Black(Pathwest Laboratory Medicine), Victoria Beshay(Peter MacCallum Cancer Centre), Marcel E. Dinger(The University of Sydney), Mark R. Davis(Pathwest Laboratory Medicine), Ben Lundie(Royal Brisbane and Women's Hospital), Karin S. Kassahn(South Australia Pathology), Huong Quang Le(Royal Prince Alfred Hospital), Michael Christie(Hudson Institute of Medical Research), Kathy Cox(South Australia Pathology), Tiffany Boughtwood(Murdoch Children's Research Institute), Lucas Dejong(South Australia Pathology), Amanda J. Hooper(Fiona Stanley Hospital), Leanne Baxter(Queensland Health), Katrina Fisk(Children's Hospital at Westmead), Kristian Brion(Queensland Health), Michael Hipwell(New South Wales Department of Health), Pak Leng Cheong(The University of Sydney), Georgina E. Hollway(The University of Adelaide), Kátia Nones(QIMR Berghofer Medical Research Institute), Evelyn Douglas(South Australia Pathology), Song Gao(South Australia Pathology), James Andrews(South Australia Pathology), Kathryn Friend(Women's and Children's Hospital), Huei San Leong(Peter MacCallum Cancer Centre), Mary McPhillips(John Hunter Hospital), Naomi L. Baker(The University of Melbourne), David Lawrence(South Australia Pathology), Kristen Palmer(Beth Israel Deaconess Medical Center), Andrew Fellowes(Peter MacCallum Cancer Centre)

The American Journal of Human Genetics

November 1, 2022

10.1016/j.ajhg.2022.10.006

Cited by 34

Related Papers

Signatures of mutational processes in human cancer

|Nature|2013|10.1k

Whole–genome characterization of chemoresistant ovarian cancer

|Nature|2015|1.7k

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

|Science Translational Medicine|2016|1.5k

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility

|Nature Genetics|2014|1.1k

Improving genetic diagnosis in Mendelian disease with transcriptome sequencing

|Science Translational Medicine|2017|809